Codiak BioSciences
Seattle, US · Founded 2015 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
DW
Doug WilliamsExecutive
Board
NA
SG
Steven GillisBoard director
EL
Eric LanderBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$31M disclosed across 1 of 2 rounds · 2015–2017
▶$76.5MofferedNov 2017 · 19 investors · BiotechnologyRule 506(b)
▶$76.5MofferedNov 2017 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles L CooneyDirector
- Eric LanderDirector
- Raghu KalluriDirector
- Noubar AfeyanDirector
- Doug WilliamsExecutive Officer, Director
- Steven GillisDirector
- Offering amount
- $76.5M
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$31MraisedNov 2015 · 12 investors · BiotechnologyRule 506(b)
▶$31MraisedNov 2015 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Noubar AfeyanDirector
- Eric LanderDirector
- Steven GillisDirector
- Doug WilliamsExecutive Officer, Director
- Amount sold
- $31M
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Codiak BioSciences went on to found or lead other companies.
Frequently asked questions
- Who are Codiak BioSciences's investors?
- Codiak BioSciences's investors include Flagship Pioneering.
- How much funding has Codiak BioSciences raised?
- Codiak BioSciences has disclosed $31M raised across 1 of its 2 known rounds.
- Where is Codiak BioSciences headquartered?
- Codiak BioSciences is headquartered in Seattle, US.